Latest filing published 12 Jan 2023 for PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.).
This profile gathers the share dealings of Ross David Carmel in PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.). Over a trading history stretching from 19 February 2021 to 5 January 2023, the count stands at 6 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 12 January 2023: a transaction, in PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.). Filings reach the SEDI feed a median of 6 days after the trade. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations